Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  HCA Holdings (Hospital Corporation America)    HCA

HCA HOLDINGS (HOSPITAL CORPORATION AMERI

(HCA)
  Report  
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Income Statement Evolution
Annual Income Statement Data
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Sales 41 490 43 614 46 677 51 159 53 963 57 206
EBITDA 8 218 8 233 8 949 9 783 10 363 10 966
Operating profit (EBIT) 6 252 6 102 6 671 7 229 7 674 8 164
Pre-Tax Profit (EBT) 4 810 4 381 5 335 5 098 5 742 6 277
Net income 2 890 2 216 3 787 3 507 3 956 4 322
P/E ratio 10,1x 14,8x 11,7x 14,0x 12,3x 11,1x
EPS ( $ ) 7,30 5,95 10,7 10,2 11,6 12,8
Dividend per Share ( $ ) - - 1,40 1,47 1,71 1,87
Yield - - 1,12% 1,03% 1,20% 1,31%
Reference price ( $ ) 74,020 87,840 124,450 142,840 142,840 142,840
Announcement Date 01/31/2017
01:30pm
01/30/2018
01:30pm
01/29/2019
01:30pm
- - -
Finances - Leverage
Actuals in M $ Estimates in M $
Fiscal Period December 2016 2017 2018 2019 (e) 2020 (e) 2021 (e)
Debt 30 730 32 326 32 319 33 486 32 625 32 045
Finance - - - - - -
Operating income (EBITDA) 8 218 8 233 8 949 9 783 10 363 10 966
Leverage
(Debt/EBITDA)
3,74x 3,93x 3,61x 3,42x 3,15x 2,92x
Capital Expenditure 2 760 3 015 3 573 4 162 3 987 4 426
Free Cash Flow (FCF) 2 893 2 411 3 188 2 563 3 359 3 776
Book Value Per Share (BVPS) ( $ ) -19,7 -18,7 -14,4 -8,18 -2,40 4,08
Cash Flow per Share ( $ ) 14,3 14,6 19,0 18,9 20,0 20,8
Announcement Date 01/31/2017
01:30pm
01/30/2018
01:30pm
01/29/2019
01:30pm
- - -
Balance Sheet Analysis
Assessed data source
© 2019 S&P Global Market Intelligence
Financial Ratios

Size 2019e 2020e
Capitalization 48 448 M $ -
Entreprise Value (EV) 81 934 M $ 81 074 M $
Valuation 2019e 2020e
P/E ratio (Price / EPS) 14,0x 12,3x
Capitalization / Revenue 0,95x 0,90x
EV / Revenue 1,60x 1,52x
EV / EBITDA 8,37x 7,91x
Yield (DPS / Price) 1,03% 1,20%
Price to book (Price / BVPS) -17,5x -59,6x
Profitability 2019e 2020e
Operating Margin (EBIT / Sales) 14,1% 14,2%
Operating Leverage (Delta EBIT / Delta Sales) 0,87x 1,12x
Net Margin (Net Profit / Revenue) 6,85% 7,33%
ROA (Net Profit / Asset) 8,44% 8,55%
ROE (Net Profit / Equities) - -
Rate of Dividend 14,4% 14,8%
Balance Sheet Analysis 2019e 2020e
CAPEX / Sales   8,14% 7,39%
Cash Flow / Sales 12,5% 12,6%
Capital Intensity (Assets / Sales) 0,81x 0,86x
Financial Leverage (Net Debt / EBITDA) 3,42x 3,15x
EPS & Dividend